Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Drake

Showing results (341-350 of 456) with videos related to

Pageof 46
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cellsDerese Getnet, Charles H Maris, Edward L Hipkiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2022
Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck CancerAleksandar Obradovic, Diana Graves, Michael Korrer, et al.
Gynecologic Oncology|May 5, 2015
Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 studySandra E Brooks, Randy L Carter, Steven C Plaxe, et al.
Mayo Clinic Proceedings|September 20, 2021
Eosinophils in Health and Disease: A State-of-the-Art ReviewMichael E Wechsler, Ariel Munitz, Steven J Ackerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate CancerMatthew C Dallos, Aleksandar Z Obradovic, Patrick McCann, et al.
Journal for Immunotherapy of Cancer|July 4, 2020
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide aloneJulie N Graff, Tomasz M Beer, Joshi J Alumkal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized TrialEmmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2004
Bacteriolytic therapy can generate a potent immune response against experimental tumorsNishant Agrawal, Chetan Bettegowda, Ian Cheong, et al.
The Journal of Pathology|November 3, 2021
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancerKara A Lombardo, Aleksandar Obradovic, Alok Kumar Singh, et al.
Cancer Research|January 5, 2013
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinomaSofia Lyford-Pike, Shiwen Peng, Geoffrey D Young, et al.
Pageof 46

Showing results (341-350 of 456) with videos related to

Sort By:
Pageof 46
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cellsDerese Getnet, Charles H Maris, Edward L Hipkiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2022
Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck CancerAleksandar Obradovic, Diana Graves, Michael Korrer, et al.
Gynecologic Oncology|May 5, 2015
Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 studySandra E Brooks, Randy L Carter, Steven C Plaxe, et al.
Mayo Clinic Proceedings|September 20, 2021
Eosinophils in Health and Disease: A State-of-the-Art ReviewMichael E Wechsler, Ariel Munitz, Steven J Ackerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate CancerMatthew C Dallos, Aleksandar Z Obradovic, Patrick McCann, et al.
Journal for Immunotherapy of Cancer|July 4, 2020
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide aloneJulie N Graff, Tomasz M Beer, Joshi J Alumkal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized TrialEmmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2004
Bacteriolytic therapy can generate a potent immune response against experimental tumorsNishant Agrawal, Chetan Bettegowda, Ian Cheong, et al.
The Journal of Pathology|November 3, 2021
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancerKara A Lombardo, Aleksandar Obradovic, Alok Kumar Singh, et al.
Cancer Research|January 5, 2013
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinomaSofia Lyford-Pike, Shiwen Peng, Geoffrey D Young, et al.
Pageof 46